GSK CEO Emma Walmsley gave an upbeat assessment of the British drugmaker's new respiratory syncytial virus (RSV) vaccine on ...

Texas' attorney general is suing Pfizer, claiming the company overstated the effectiveness of its COVID-19 vaccine.

The US Food and Drug Administration (FDA ... U.S. are eligible to receive this season's Covid-19 vaccine, even if they have never been vaccinated against Covid-19 before,” Albert Bourla, Pfizer ...

The lawsuit alleges Pfizer violated Texas’ Deceptive Trade Practices Act by engaging in “false, deceptive, and misleading ...

Reuters reported in October that Pfizer's shot was lagging behind the GSK vaccine, which accounted for close to two-thirds of RSV shots given in the U.S. since early September. GSK was helped by being ...

United States health authorities Monday gave full approval to the COVID-19 vaccine developed by Pfizer ... Moderna's drug is expected to be approved shortly. The Food and Drug Administration's ...

Of the roughly 14,000 doses requested by CT, only about 10,000 have been received and distributed, CT public health officials ...

Two top federal health officials reportedly warned the Biden administration Thursday they might not rubber-stamp COVID vaccine ... FDA’s outside advisory committee is due to publicly review ...

the Pfizer vaccine was approved for emergency use. The decision to give it full approval is likely to prompt more community college districts in California to require students or staff to be ...

Pfizer and BioNTech requested that the Food and Drug Administration expand vaccine authorization for children ages 12 ... “These submissions represent a critical step in Pfizer’s and BioNTech’s ...

News, May 07, 2010 FDA Approves Orphan Drug Status for Pancreatic Cancer Vaccine The FDA has approved ... for the treatment of pediatric Crohn's disease. News, January 18, 2008 New FDA Orphan ...

NEW YORK (AP) — Flu is picking up steam while RSV lung infections that can hit kids and older people hard may be peaking, U.S ...